MDM2 Overexpression Deregulates the Transcriptional Control of RB/E2F Leading to DNA Methyltransferase 3A Overexpression in Lung Cancer

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-11-2617

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Clinicopathologic Significance of DNA Methyltransferase 1, 3a, and 3b Overexpression in Tunisian Breast Cancers

Human Pathology
Forensic MedicinePathology
2012English

Significance of Pathways Leading to RhoC Overexpression in Breast Cancer

2005English

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Science
MultidisciplinaryPhilosophy of ScienceHistory
2008English

Epigenetic Alterations Leading to TMPRSS4 Promoter Hypomethylation and Protein Overexpression Predict Poor Prognosis in Squamous Lung Cancer Patients

Oncotarget
Oncology
2016English

The Interaction of RB With E2F Coincides With an Inhibition of the Transcriptional Activity of E2F.

Genes and Development
GeneticsDevelopmental Biology
1992English

Overexpression of Kpnβ1 and Kpnα2 Importin Proteins in Cancer Derives From Deregulated E2F Activity

PLoS ONE
Multidisciplinary
2011English

Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex

American Journal of Pathology
Forensic MedicinePathology
2007English

16P the Overexpression of SASH1 Stimulates Cell Death in Lung Cancer Cells

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Overexpression of WDR79 in Non-Small Cell Lung Cancer Is Linked to Tumour Progression

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy